The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Ewing, New Jersey-based Church & Dwight Co., Inc. (CHD) develops, manufactures, and markets household, personal care, and specialty products. Valued at $22.9 billion by market cap, the company offers contraceptive products, laundry and dishwashing detergents, toothbrushes, shampoos, vitamins, pregnancy test kits, and hair removers.

Shares of this leading U.S. producer of sodium bicarbonate have underperformed the broader market over the past year. CHD has declined marginally over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 23.3%. However, in 2026, CHD stock is up 14.2%, surpassing SPX’s 7.4% rise on a YTD basis.

NVDA Earnings Bull Put Spread has a High Probability of Success

This High-Yield REIT Just Hiked Its Dividend By 7.1%. Its Shares Look Compelling Here.

Warren Buffett’s Berkshire Hathaway Dumped 16 Stocks in Q1, But the Chevron Sale Was the Largest

Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now!

Narrowing the focus, CHD’s underperformance is also apparent compared to the State Street Consumer Staples Select Sector SPDR ETF (XLP). The exchange-traded fund has gained about 4.6% over the past year. However, the stock’s gains on a YTD basis outshine the ETF’s 10.8% returns over the same time frame.

On May 1, CHD shares closed down more than 1% after reporting its Q1 results. Its adjusted EPS of $0.95 exceeded Wall Street expectations of $0.93. The company’s revenue was $1.5 billion, meeting Wall Street forecasts.

For the current fiscal year, ending in December, analysts expect CHD’s EPS to grow 6.5% to $3.76 on a diluted basis. The company’s earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters.

Among the 20 analysts covering CHD stock, the consensus is a “Moderate Buy.” That’s based on eight “Strong Buy” ratings, two “Moderate Buys,” nine “Holds,” and one “Strong Sell.”

The configuration has been consistent over the past months.

On May 13, Nik Modi from RBC Capital maintained a “Buy” rating on CHD, with a price target of $114, implying a potential upside of 19.1% from current levels.

The mean price target of $103.78 represents an 8.4% premium to CHD’s current price levels. The Street-high price target of $115 suggests an upside potential of 20.1%.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com